31.12.2014 13:31:32
|
Press Release: MorphoSys AG : Publication pursuant to --26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution
MorphoSys AG / MorphoSys AG : Publication pursuant to --26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
MorphoSys AG
Lena-Christ-Str. 48
82152 Martinsried/Planegg
Germany
The number of voting rights of the share capital of MorphoSys AG increased through the exercise of stock options and convertible bonds. As of the end of the month of December 2014, the number of total voting rights amounted to 26,456,834.
Contact:
MorphoSys AG
Dr. Claudia Gutjahr-Löser
Head of Corporate Communications & Investor Relations
Tel.: +49 89 899 27 122
investors@morphosys.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MorphoSys AG via Globenewswire
HUG#1882005
--- End of Message ---
MorphoSys AG
Lena-Christ-Str. 48 Martinsried / Munich Germany
WKN: 663200;ISIN: DE0006632003;Index:TecDAX,CDAX,Prime All Share,TECH All Share,HDAX,MIDCAP;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
http://www.morphosys.com (END) Dow Jones Newswires
December 31, 2014 07:00 ET (12:00 GMT)- - 07 00 AM EST 12-31-14
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MorphoSysmehr Nachrichten
Analysen zu MorphoSysmehr Analysen
06.05.24 | MorphoSys Neutral | UBS AG | |
30.04.24 | MorphoSys Neutral | UBS AG | |
16.02.24 | MorphoSys Neutral | UBS AG | |
07.02.24 | MorphoSys Neutral | UBS AG | |
07.02.24 | MorphoSys Buy | UBS AG |
Aktien in diesem Artikel
MorphoSys | 67,80 | -0,95% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 175,58 | 0,63% |